IBDEI2IA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40015,1,3,0)
 ;;=3^Cirrhosis of Liver,Oth
 ;;^UTILITY(U,$J,358.3,40015,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,40015,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,40016,0)
 ;;=K74.60^^152^2003^11
 ;;^UTILITY(U,$J,358.3,40016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40016,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,40016,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,40016,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,40017,0)
 ;;=K76.0^^152^2003^12
 ;;^UTILITY(U,$J,358.3,40017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40017,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,40017,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,40017,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,40018,0)
 ;;=K76.89^^152^2003^18
 ;;^UTILITY(U,$J,358.3,40018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40018,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,40018,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,40018,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,40019,0)
 ;;=K71.6^^152^2003^32
 ;;^UTILITY(U,$J,358.3,40019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40019,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,40019,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,40019,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,40020,0)
 ;;=K75.9^^152^2003^17
 ;;^UTILITY(U,$J,358.3,40020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40020,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,40020,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,40020,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,40021,0)
 ;;=K71.0^^152^2003^24
 ;;^UTILITY(U,$J,358.3,40021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40021,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,40021,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,40021,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,40022,0)
 ;;=K71.10^^152^2003^30
 ;;^UTILITY(U,$J,358.3,40022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40022,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,40022,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,40022,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,40023,0)
 ;;=K71.11^^152^2003^31
 ;;^UTILITY(U,$J,358.3,40023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40023,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,40023,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,40023,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,40024,0)
 ;;=K71.2^^152^2003^23
 ;;^UTILITY(U,$J,358.3,40024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40024,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,40024,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,40024,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,40025,0)
 ;;=K71.3^^152^2003^28
 ;;^UTILITY(U,$J,358.3,40025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40025,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,40025,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,40025,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,40026,0)
 ;;=K71.4^^152^2003^27
 ;;^UTILITY(U,$J,358.3,40026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40026,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,40026,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,40026,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,40027,0)
 ;;=K75.81^^152^2003^19
 ;;^UTILITY(U,$J,358.3,40027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40027,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
